Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

CKS1B Mediates SKP2/p27Kip1-Independent Myeloma Cell Survival and Disease Progression through Activation of MEK/ERK and JAK/STAT3 Signaling Pathways.

Fenghuang Zhan, MD, PhD, Lei Shi, MD, Siqing Wang, MD, MS, Hongwei Xu, MD, Thai M. Cao, MD, Chunjiao Xu, MD, PhD, Yong Wu, MD, PhD, Maurizio Zangari, MD, Guiyuan Li, MD, PhD, Guido J. Tricot, MD, PhD

Blood (2009) 114 (22): 126.

https://doi.org/10.1182/blood.V114.22.126.126

Published: 2009

Journal Articles

Potential Eradication of Myeloma Stem Cells by Combining ATRA with WNT and HH Signaling Pathways Inhibitors.

Guido J. Tricot, MD, PhD, Siqing Wang, MD, MS, Lei Shi, MD, Hongwei Xu, MD, Chunjiao Xu, MD, PhD, Maurizio Zangari, MD, Fenghuang Zhan, MD, PhD

Blood (2009) 114 (22): 2839.

https://doi.org/10.1182/blood.V114.22.2839.2839

Published: 2009

Journal Articles

Combination of ATRA with a COX2 Inhibitor Induces Synergistic Effects On RARalpha2-Expressing Multiple Myeloma (MM) Cells.

Siqing Wang, MD, MS, Lei Shi, MD, Hongwei Xu, MD, Chunjiao Xu, MD, PhD, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD

Blood (2009) 114 (22): 2809.

https://doi.org/10.1182/blood.V114.22.2809.2809

Published: 2009

Journal Articles

Arsenic Trioxide-Mediated Growth Inhibition of Myeloma Cells Is Associated with An Extrinsic Signaling Pathway Involved in Caspase 3 and Caspase 8.

Jumei Shi, MD., PhD, Yi Wu, Siqing Wang, MD, MS, Xiuqin Meng, MD., Rong Wei, MD., Xiaojing Hu, MD., PhD, Maurizio Zangari, MD, Guido J. Tricot, MD., PhD, Fenghuang Zhan, MD, PhD

Blood (2009) 114 (22): 4899.

https://doi.org/10.1182/blood.V114.22.4899.4899

Published: 2009

Journal Articles

Optimizing Immunotherapy in Multiple Myeloma: Restoring the Function of Patient’s Monocyte-Derived Dendritic Cells by Inhibiting p38 or Activating MEK/ERK MAPK and Neutralizing Interleukin-6 in the Progenitor Cells.

Qing Yi, MD, PhD, Siqing Wang, MD, Sungyoul Hong, PhD, Jing Yang, PhD, Jianfei Qian, PhD, Xiang Zhang, MS, Elizabeth Shpall, MD, Larry W. Kwak, MD, PhD

Blood (2006) 108 (11): 3701.

https://doi.org/10.1182/blood.V108.11.3701.3701

Published: 2006

Journal Articles

Atiprimod Inhibits Growth of Mantle Cell Lymphoma In Vitro and In Vivo and Induces Apoptosis Via Activation of the Mitochondrial Pathway.

Michael Wang, MD, Liang Zhang, PhD, Xiaohong Han, PhD, Jin Yang, MD, Jianfei Qian, MD, Siqing Wang, MD, Sungyoul Hong, MD, Xiang Zhang, MD, Yuhong Zhou, MD, Jorge Romaguera, MD, Qing Yi, MD,PhD

Blood (2006) 108 (11): 2514.

https://doi.org/10.1182/blood.V108.11.2514.2514

Published: 2006

Journal Articles

Dendritic Cell Vaccines Are Superior to Idiotype-KLH Protein Vaccines at Priming a Therapeutic, Tumor-Specific Immunity Against Multiple Myeloma.

Qing Yi, MD, PhD, Siqing Wang, MD, Michele Wezeman, Jianfei Qian, PhD, Jing Yang, PhD

Blood (2005) 106 (11): 3466.

https://doi.org/10.1182/blood.V106.11.3466.3466

Published: 2005

Journal Articles

DKK-1 Is a Widely Expressed, Potent Tumor-Associated Antigen in Multiple Myeloma Recognized by Cytotoxic T Lymphocytes.

Qing Yi, MD, PhD, Jianfei Qian, PhD, Jing Yang, PhD, Siqing Wang, MD, Fenghuang Zhan, MD, PhD, John D. Shaughnessy, Jr., PhD, Michele Wezeman

Blood (2005) 106 (11): 3467.

https://doi.org/10.1182/blood.V106.11.3467.3467

Published: 2005

Journal Articles

Tumor Evasion of the Immune System: Inhibiting p38 MAP Kinase Signaling Restores the Function of Dendritic Cells.

Qing Yi, MD, PhD, Siqing Wang, MD, Jing Yang, PhD, Jianfei Wang, PhD, Michele Wezeman, Larry W. Kwak, MD, PhD.

Blood (2005) 106 (11): 2512.

https://doi.org/10.1182/blood.V106.11.2512.2512

Published: 2005

Journal Articles

Targeting β 2 -Microglobulin for Induction of Tumor Apoptosis in Human Hematological Malignancies.

Qing Yi, MD, PhD, Jing Yang, PhD, Jianfei Qian, PhD, Siqing Wang, MD, Michele Wezeman, Larry W. Kwak, MD, PhD

Blood (2005) 106 (11): 618.

https://doi.org/10.1182/blood.V106.11.618.618

Published: 2005

Journal Articles

Myeloma Cell-Derived Factors Retard the Differentiation and Function of Dendritic Cells.

Qing Yi, MD, PhD, Siqing Wang, MD, Jin Xie, PhD, Jianfei Qian, PhD, Jin Yang, PhD, Muta E. Freeman, BS, Bart Barlogie, MD, PhD

Blood (2004) 104 (11): 2447.

https://doi.org/10.1182/blood.V104.11.2447.2447

Published: 2004

Journal Articles

Generation of Tumor-Specific Cytotoxic T Lymphocytes in Multiple Myeloma Using Dendritic Cells Pulsed with Tumor-Derived Heat Shock Protein gp96.

Qing Yi, MD, PhD, Jianfei Qian, PhD, Jin Xie, PhD, Siqing Wang, MD, Muta E. Freeman, BS, Bart Barlogie, MD, PhD

Blood (2004) 104 (11): 2451.

https://doi.org/10.1182/blood.V104.11.2451.2451

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

CKS1B Mediates SKP2/p27Kip1-Independent Myeloma Cell Survival and Disease Progression through Activation of MEK/ERK and JAK/STAT3 Signaling Pathways.

Potential Eradication of Myeloma Stem Cells by Combining ATRA with WNT and HH Signaling Pathways Inhibitors.

Combination of ATRA with a COX2 Inhibitor Induces Synergistic Effects On RARalpha2-Expressing Multiple Myeloma (MM) Cells.

Arsenic Trioxide-Mediated Growth Inhibition of Myeloma Cells Is Associated with An Extrinsic Signaling Pathway Involved in Caspase 3 and Caspase 8.

Optimizing Immunotherapy in Multiple Myeloma: Restoring the Function of Patient’s Monocyte-Derived Dendritic Cells by Inhibiting p38 or Activating MEK/ERK MAPK and Neutralizing Interleukin-6 in the Progenitor Cells.

Atiprimod Inhibits Growth of Mantle Cell Lymphoma In Vitro and In Vivo and Induces Apoptosis Via Activation of the Mitochondrial Pathway.

Dendritic Cell Vaccines Are Superior to Idiotype-KLH Protein Vaccines at Priming a Therapeutic, Tumor-Specific Immunity Against Multiple Myeloma.

DKK-1 Is a Widely Expressed, Potent Tumor-Associated Antigen in Multiple Myeloma Recognized by Cytotoxic T Lymphocytes.

Tumor Evasion of the Immune System: Inhibiting p38 MAP Kinase Signaling Restores the Function of Dendritic Cells.

Targeting β 2 -Microglobulin for Induction of Tumor Apoptosis in Human Hematological Malignancies.

Myeloma Cell-Derived Factors Retard the Differentiation and Function of Dendritic Cells.

Generation of Tumor-Specific Cytotoxic T Lymphocytes in Multiple Myeloma Using Dendritic Cells Pulsed with Tumor-Derived Heat Shock Protein gp96.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only